Sullivan K M, Storb R
Cancer Invest. 1984;2(1):27-38. doi: 10.3109/07357908409020284.
After 15 years of clinical investigation, allogeneic marrow transplantation can be considered the treatment of choice for a variety of hematologic and immunologic diseases. This review has focused upon some of the principles, current results, problems, and future directions in allogeneic marrow grafting.